Skip to content
CISO Spotlights

Interim and acting CISO record

ALX Oncology's Chief Accounting Officer Doubles as Acting CISO

ALX Oncology's 2025 10-K states its Chief Accounting Officer serves as the company's acting Chief Information Security Officer.

Company
ALX Oncology Holdings Inc. (ALXO)
Acting CISO
Not named in the filing
Filing
10-K
Filed
9 March 2026

By the CISO Spotlights Desk · Published

ALX Oncology's annual report for fiscal year 2025 puts its finance chief in charge of the company's security program on an acting basis, alongside outside technology help.

The filing identifies "our Chief Accounting Officer (CAO), who serves as our acting Chief Information Security Officer (CISO)," alongside outside IT consultants, as the company's designated high-level personnel for managing cybersecurity risk.

The filing does not name the Chief Accounting Officer or say when the acting designation began. ALX Oncology's own prior-year 10-K, filed March 2025, carries the identical disclosure, indicating the arrangement has held for at least a year.

See the interim and acting CISO record for other companies naming a temporary security leader in an SEC filing, with no comparison or ranking implied.

Sources

  1. 1.
    ALX Oncology Holdings Inc., Form 10-K (SEC EDGAR)sec.gov · published 9 March 2026 · tier A

Tier A: the organization itself, a regulator or a government page. Tier B: established trade or business press.

See an error? Request a correction.